Canopy Biosciences
Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Core Diagnostics
Acquisition in 2019
Core Diagnostics Private Limited, established in 2012 and located in Gurugram, India, is a clinical laboratory specializing in advanced diagnostic solutions aimed at disease stratification and therapy selection. The company emphasizes the use of next-generation diagnostic techniques to enhance healthcare outcomes, striving to provide comprehensive and high-quality testing services. With a commitment to innovation, Core Diagnostics aims to be a leading provider of sophisticated diagnostic solutions in India, catering to the growing demand for precision medicine.
Zellkraftwerk
Acquisition in 2019
Zellkraftwerk GmbH, based in Leipzig, Germany, specializes in the development and manufacturing of workflow solutions for cytometry focused on cells and tissues. The company produces a range of products, including instruments, devices, consumables, and software, designed to facilitate high-content cytometry. Their technology enables the analysis of over 100 markers per cell, providing comprehensive capabilities for sample preparation, biobanking, multiplexed protein and biomarker analysis, and data mining. Additionally, Zellkraftwerk offers research services to complement their product offerings, enhancing the efficiency and effectiveness of cell analysis for their clients. As of April 2019, Zellkraftwerk operates as a subsidiary of Canopy Biosciences.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.